Edward O'Mara Selected Research

vicriviroc

10/2011	Effect of vicriviroc with or without ritonavir on oral contraceptive pharmacokinetics: a randomized, open-label, parallel-group, fixed-sequence crossover trial in healthy women.
4/2011	Pharmacokinetic interaction of vicriviroc with other antiretroviral agents: results from a series of fixed-sequence and parallel-group clinical trials.
6/2010	Renal insufficiency has no effect on the pharmacokinetics of vicriviroc in a ritonavir-containing regimen.
1/2010	Short-term administration of the CCR5 antagonist vicriviroc to patients with HIV and HCV coinfection is safe and tolerable.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edward O'Mara Research Topics

Disease

3	Infections 01/2018 - 09/2012
2	Body Weight (Weight, Body) 01/2021 - 11/2004
2	Multiple Myeloma 01/2017 - 02/2016
2	Coinfection 03/2013 - 01/2010
2	Chronic Kidney Failure (Chronic Renal Failure) 09/2012 - 06/2010
2	HIV Infections (HIV Infection) 04/2011 - 10/2005
1	Neoplasms (Cancer) 01/2021
1	Injection Site Reaction 02/2015
1	Thrombophlebitis 02/2015
1	Hepatitis C 03/2013
1	Thrombosis (Thrombus) 09/2012
1	Ventricular Premature Complexes (Premature Ventricular Contraction) 09/2012
1	Vomiting 09/2012
1	Chronic Hepatitis C 09/2012
1	Flatulence 09/2012
1	Headache (Headaches) 10/2011
1	Cardiac Arrhythmias (Arrythmia) 06/2010
1	Renal Insufficiency (Renal Failure) 06/2010
1	Liver Diseases (Liver Disease) 01/2010
1	Substance-Related Disorders (Drug Abuse) 10/2005
1	Opioid-Related Disorders (Opiate Addiction) 10/2005
1	Type 2 Diabetes Mellitus (MODY) 11/2004
1	Insulin Resistance 11/2004

Drug/Important Bio-Agent (IBA)

4	Ritonavir (Norvir)FDA Link 10/2011 - 11/2004
4	vicrivirocIBA 10/2011 - 01/2010
3	Pharmaceutical PreparationsIBA 01/2021 - 06/2010
2	pomalidomideIBA 01/2017 - 02/2016
2	Methadone (Dolophine)FDA LinkGeneric 03/2015 - 10/2005
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 03/2013 - 09/2012
2	Atazanavir Sulfate (Reyataz)FDA Link 10/2005 - 11/2004
1	TubulinIBA 01/2021
1	PTC596IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2018
1	elbasvirIBA 01/2018
1	grazoprevirIBA 01/2018
1	Opioid Analgesics (Opioids)IBA 03/2015
1	Naloxone Drug Combination Buprenorphine FDA Link 03/2015
1	posaconazole FDA Link 02/2015
1	SolutionsIBA 02/2015
1	Peptide Hydrolases (Proteases)FDA Link 09/2012
1	Cytochrome P-450 CYP3A InhibitorsIBA 06/2010
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 06/2010
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2010
1	RNA (Ribonucleic Acid)IBA 01/2010
1	Opiate AlkaloidsIBA 10/2005
1	HIV Protease InhibitorsIBA 11/2004
1	Insulin (Novolin)FDA Link 11/2004
1	Glucose (Dextrose)FDA LinkGeneric 11/2004
1	Lopinavir FDA Link 11/2004

Therapy/Procedure

1	Oral Administration 01/2018
1	Catheters 09/2012
1	Therapeutics 11/2004